Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-Center Study of the Braive™ Growth Modulation System When Used in the Treatment of Pediatric Patients Diagnosed With Juvenile or Adolescent Idiopathic Scoliosis

NCT04929678 is registered in ClinicalTrials.gov with Medtronic Spinal and Biologics as lead sponsor.

NCT NCT04929678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04929678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-Center Study of the Braive™ Growth Modulation System When Used in the Treatment of Pediatric Patients Diagnosed With Juvenile or Adolescent Idiopathic Scoliosis
Lead sponsor
Medtronic Spinal and Biologics
Phase
Not applicable
Overall status
Terminated
Start date
August 12, 2021
Completion date
January 14, 2026
Enrollment
10 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent idiopathic scoliosis, juvenile idiopathic scoliosis